Autologous T regulatory cells: Phase II started

Caladrius began the double-blind, placebo-controlled, U.S. Phase II T-Rex Study trial to evaluate single infusions of 2 dose levels of CLBS03 in about 111 patients ages 12-17. The Sanford Research sub...